A tax-advantaged biologics manufacturing hub with FDA & EU reach. Compare HPRA-regulated Irish CDMOs across biologics, API, and drug product — by capability and site.
47 companies listed
Ireland has become one of Europe's most important biologics and pharmaceutical manufacturing locations, driven by favorable tax policy that attracted decades of investment from global pharma. Its CDMO and captive-manufacturing base spans biologics, API synthesis, and drug product, clustered around Dublin, Cork, and the Shannon region.
Irish facilities operate under EU GMP via the HPRA, recognized across the EU, and Ireland's long history of FDA-inspected manufacturing means many sites carry both EU and US approvals. As an English-speaking EU member, Ireland uniquely bridges EU regulatory standing with US-market familiarity.
For sponsors who want EU manufacturing with deep FDA-export experience and an English-language operating environment, Ireland is a strategically attractive base — particularly for biologics and high-value drug product.
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Our AI Matchmaker analyzes your project requirements and matches you with qualified Ireland manufacturing partners. Free for buyers.